United States · Funded startup

Who invested in IFM Therapeutics

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$83Mraised across 2 rounds since 2016, from 2 sources

$27MSeries A$56MRound
Latest round
Round, $56MDec 2019
Led by
Omega Funds
Step-upi
2.1×
Investors
5 (1 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201720182019
$27MSeries A$56MRound
First round
Series A, $27M
Jun 2016
Biggest round
$56M
Round · Dec 2019
Between rounds
3.4 years
from the last two

The rounds

  1. Dec 2019
  2. Jun 2016
    Series A$27M1 new
    • Atlas Venture & Abingworth

    Reported by Cbs8SEC filing: $17M sold, first sale Jun 2016

Founders and team

From IFM Therapeutics's own website and the SEC filings it signed: 1 founder, 8 on the team.

Anthony OpipariIFM Co-Founder
  • Christopher M. LindblomVice President, Finance
  • Ed OlhavaSenior Vice President of Preclinical Development
  • William R. RoushExecutive Vice President of Chemistry
  • Dennis DeanChief Development Officer
  • H. Martin SeidelBoard Director
  • Vincent MilesBoard Director
  • Gary D. GlickBoard Director
  • Jean-Francois FormelaBoard Director

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2016Round2019Omega FundsLAtlas VentureNovartisAbingworthAtlas Venture & Abingworth

Everyone who backed them

Omega FundsVC firm1round, led 1
Atlas VentureVC firm1round
NovartisVC firm1round
AbingworthVC firm1round
Atlas Venture & Abingworthno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about IFM Therapeutics

Who invested in IFM Therapeutics?

IFM Therapeutics's investors include Omega Funds, Atlas Venture, Novartis, Abingworth and Atlas Venture & Abingworth. Omega Funds led its latest round.

How much has IFM Therapeutics raised?

IFM Therapeutics has raised $83M across 2 rounds since 2016.

When did IFM Therapeutics last raise?

IFM Therapeutics's most recent round was an Undisclosed round of $56M in Dec 2019, led by Omega Funds.

What was IFM Therapeutics's biggest round?

Its most recent round, $56M in Dec 2019, is also its largest on record.

Who backed IFM Therapeutics first?

IFM Therapeutics's first round on record, in Jun 2016, was backed by Atlas Venture & Abingworth.

What stage is IFM Therapeutics at?

IFM Therapeutics's latest named round is an Undisclosed round, in Dec 2019.

Where is IFM Therapeutics based?

IFM Therapeutics is based in the United States.

Who led IFM Therapeutics's rounds?

Omega Funds led the Undisclosed round in 2019.

Companies like IFM Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.